检索结果 - Yoshiki Arakawa
- Showing 1 - 20 results of 34
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution 由 Kengo Ogura, Takashi Mizowaki, Yoshiki Arakawa, Masakazu Ogura, Katsuyuki Sakanaka, Susumu Miyamoto, Masahiro Hiraoka
出版 2013Artigo -
6
-
7
-
8
-
9
Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study 由 Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori
出版 2023Artigo -
10
-
11
Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG 1 for recurrent glioblastoma 由 Shoichi Deguchi, Fumiharu Ohka, Yoshiki Shiba, Junya Yamaguchi, Aya Sato, Keiko Shinjo, Yoshiki Arakawa, Yoshitaka Narita, Yutaka Kondo, Ryuta Saito
出版 2025Artigo -
12
-
13
Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan 由 Toshihiko Iuchi, Akihiro Inoue, Yuichi Hirose, Motohiro Morioka, Keishi Horiguchi, Atsushi Natsume, Yoshiki Arakawa, Koichi Iwasaki, Minoru Fujiki, Toshihiro Kumabe, Yukinori Sakata
出版 2022Artigo -
14
Dummy run study for outlining and plan quality of intensity-modulated radiotherapy in elderly patients with newly diagnosed glioblastoma: The Japan clinical oncology group study JC... 由 Tomohiro Ono, Megumi Uto, Yohei Mineharu, Yoshiki Arakawa, Mitsuhiro Nakamura, Teiji Nishio, Hiroshi Igaki, Keiji Nihei, Satoshi Ishikura, Yoshitaka Narita, Takashi Mizowaki
出版 2025Artigo -
15
ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts 由 Takahiro Tsuji, Toshimasa Ishizaki, Muneo Okamoto, Chiharu Higashida, Kazuhiro Kimura, Tomoyuki Furuyashiki, Yoshiki Arakawa, Raymond B. Birge, Tetsuya Nakamoto, Hisamaru Hirai, Shuh Narumiya
出版 2002Artigo -
16
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma 由 Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
出版 2024Artigo -
17
Intraoperative dorsal language network mapping by using single‐pulse electrical stimulation 由 Yukihiro Yamao, Riki Matsumoto, Takeharu Kunieda, Yoshiki Arakawa, Katsuya Kobayashi, Kiyohide Usami, Sumiya Shibata, Takayuki Kikuchi, Nobukatsu Sawamoto, Nobuhiro Mikuni, Akio Ikeda, Hidenao Fukuyama, Susumu Miyamoto
出版 2014Artigo -
18
High programmed cell death 1 ligand–1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma 由 Daiki Murata, Yohei Mineharu, Yoshiki Arakawa, Bin Liu, Masahiro Tanji, Yamaguchi Makoto, Koichi Fujimoto, Nobuyuki Fukui, Yukinori Terada, Ryuta Yokogawa, Maki Yamaguchi, Sachiko Minamiguchi, Susumu Miyamoto
出版 2017Artigo -
19
Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma 由 Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Junsaku Kitagawa, Arata Aoi, Ryo Nishikawa
出版 2020Artigo -
20
The Rho-mDia1 Pathway Regulates Cell Polarity and Focal Adhesion Turnover in Migrating Cells through Mobilizing Apc and c-Src 由 Norikazu Yamana, Yoshiki Arakawa, Tomohiro Nishino, Kazuo Kurokawa, Masahiro Tanji, Reina E. Itoh, James Monypenny, Toshimasa Ishizaki, Haruhiko Bito, Kazuhiko Nozaki, Nobuo Hashimoto, Michiyuki Matsuda, Shuh Narumiya
出版 2006Artigo
相关主题
Medicine
Internal medicine
Biology
Cancer research
Biochemistry
Cell biology
Gene
Oncology
Cell
Chemotherapy
Pathology
Glioma
Signal transduction
Genetics
Neuroscience
Radiation therapy
Surgery
Adverse effect
Clinical trial
Cytoskeleton
Glioblastoma
Actin
CDC42
Disease
Physics
RHOA
Radiology
Actin cytoskeleton
Chemistry
Clinical endpoint